Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta, Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.

There are 587 beds in Emory University Hospital/Winship Cancer Institute.

During the past decade, Emory University Hospital/Winship Cancer Institute conducted 635 clinical trials. In the 10-year time frame, 635 clinical trials started and 359 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 276 clinical trials started and 186 clinical trials were completed. i.e. 67.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory University Hospital/Winship Cancer Institute" #1 sponsor was "Emory University" with 182 trials, followed by "National Cancer Institute (NCI)" with 172 trials sponsored, "Bristol-Myers Squibb" with 39 trials sponsored, "Children's Oncology Group" with 30 trials sponsored and "Alliance for Clinical Trials in Oncology" with 30 trials sponsored. Other sponsors include 635 different institutions and companies that sponsored additional 246 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory University Hospital/Winship Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 308 trials as a collaborator, "NRG Oncology" with 50 trials as a collaborator, "Bristol-Myers Squibb" with 24 trials as a collaborator, "Merck Sharp & Dohme LLC" with 23 trials as a collaborator and "Canadian Cancer Trials Group" with 14 trials as a collaborator. Other collaborators include 418 different institutions and companies that were collaborators in the rest 204 trials.

According to Clinical.Site data, the most researched conditions in "Emory University Hospital/Winship Cancer Institute" are "Multiple Myeloma" (69 trials), "Breast Cancer" (46 trials), "Lymphoma" (31 trials), "Melanoma" (26 trials) and "Prostate Cancer" (23 trials). Many other conditions were trialed in "Emory University Hospital/Winship Cancer Institute" in a lesser frequency.

Most popular intervention types in "Emory University Hospital/Winship Cancer Institute" are "Drug" (873 trials), "Biological" (280 trials), "Other" (247 trials), "Radiation" (183 trials) and "Procedure" (165 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (112 trials), "Quality-of-Life Assessment" (77 trials), "Nivolumab" (69 trials), "Cisplatin" (56 trials) and "Placebo" (53 trials). Other intervention names were less common.

The vast majority of trials in "Emory University Hospital/Winship Cancer Institute" are 972 trials for "All" genders, 70 trials for "Female" genders and 50 trials for "Male" genders.

Currently, there are 507 active trials in "Emory University Hospital/Winship Cancer Institute". 6 are not yet recruiting, 243 are recruiting, 256 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 421 completed trials in Emory University Hospital/Winship Cancer Institute, 11 suspended trials, and 123 terminated clinical trials to date.

Out of the total trials that were conducted in Emory University Hospital/Winship Cancer Institute, 321 "Phase 1" clinical trials were conducted, 538 "Phase 2" clinical trials and 282 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 50 trials that are defined as “Not Applicable".